Market Whales and Their Recent Bets on REGN Options

Benzinga2minutes ago

(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest

Benzinga51minutes ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)?

Simply Wall StOct 1 19:38

$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today

BenzingaSep 30 23:00

Erste Group Downgrades Regeneron Pharmaceuticals(REGN.US) to Hold Rating

Futu NewsSep 30 20:34 · Ratings

Barclays Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,220

Futu NewsSep 30 15:32 · Ratings